Shopping Cart 0
Cart Subtotal
USD 0

Biosceptre International Ltd - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers. The company also develops diagnostics and a line of veterinary therapeutic products. It has operations in the UK, Australia, and the US. Biosceptre is headquartered in Cambridge, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Biosceptre International Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Biosceptre International Ltd Company Overview 4

Biosceptre International Ltd Company Snapshot 4

Biosceptre International Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Biosceptre International Ltd-Pipeline Analysis Overview 6

Biosceptre International Ltd-Key Facts 6

Biosceptre International Ltd-Major Products and Services 7

Biosceptre International Ltd Pipeline Products by Development Stage 8

Biosceptre International Ltd Pipeline Products Overview 10

BPM09-IHC Antibody Diagnostic Assay 10

BPM09-IHC Antibody Diagnostic Assay Product Overview 10

Breast Cancer IHC Diagnostic Test 11

Breast Cancer IHC Diagnostic Test Product Overview 11

Fluid Based Diagnostic Test-Cancer 12

Fluid Based Diagnostic Test-Cancer Product Overview 12

mAb based IHC Diagnostic Test 13

mAb based IHC Diagnostic Test Product Overview 13

Prostate Cancer IHC Diagnostic Test 14

Prostate Cancer IHC Diagnostic Test Product Overview 14

Skin Cancer IHC Diagnostic Test 15

Skin Cancer IHC Diagnostic Test Product Overview 15

Biosceptre International Ltd-Key Competitors 16

Biosceptre International Ltd-Key Employees 17

Biosceptre International Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Biosceptre International Ltd, Recent Developments 19

Feb 21, 2014: Biosceptre moves corporate headquarters to the UK from Australia 19

Appendix 20

Methodology 20

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Biosceptre International Ltd Pipeline Products by Equipment Type 5

Biosceptre International Ltd Pipeline Products by Development Stage 8


List Of Table

List of Tables

Biosceptre International Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

Biosceptre International Ltd Pipeline Products by Equipment Type 5

Biosceptre International Ltd Pipeline Products by Indication 5

Biosceptre International Ltd, Key Facts 6

Biosceptre International Ltd, Major Products and Services 7

Biosceptre International Ltd Number of Pipeline Products by Development Stage 8

Biosceptre International Ltd Pipeline Products Summary by Development Stage 9

BPM09-IHC Antibody Diagnostic Assay-Product Status 10

BPM09-IHC Antibody Diagnostic Assay-Product Description 10

Breast Cancer IHC Diagnostic Test-Product Status 11

Breast Cancer IHC Diagnostic Test-Product Description 11

Fluid Based Diagnostic Test-Cancer-Product Status 12

Fluid Based Diagnostic Test-Cancer-Product Description 12

mAb based IHC Diagnostic Test-Product Status 13

mAb based IHC Diagnostic Test-Product Description 13

Prostate Cancer IHC Diagnostic Test-Product Status 14

Prostate Cancer IHC Diagnostic Test-Product Description 14

Skin Cancer IHC Diagnostic Test-Product Status 15

Skin Cancer IHC Diagnostic Test-Product Description 15

Biosceptre International Ltd, Key Employees 17

Biosceptre International Ltd, Subsidiaries 18

Glossary 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Biosceptre International Ltd,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Oxford BioTherapeutics Ltd

Mina Therapeutics Ltd

Tyg Oncology Ltd